LHC Group, Inc. (NASDAQ:LHCG) Given Average Recommendation of “Hold” by Analysts

Shares of LHC Group, Inc. (NASDAQ:LHCGGet Rating) have received a consensus rating of “Hold” from the thirteen brokerages that are presently covering the firm, MarketBeat reports. Twelve investment analysts have rated the stock with a hold rating. The average 12-month price objective among brokers that have covered the stock in the last year is $164.43.

Several research analysts have commented on the company. Stephens downgraded LHC Group from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, March 30th. William Blair downgraded LHC Group from an “outperform” rating to a “market perform” rating in a research note on Tuesday, March 29th. Royal Bank of Canada downgraded LHC Group from an “outperform” rating to a “sector perform” rating and cut their target price for the stock from $172.00 to $170.00 in a research note on Monday, April 4th. Credit Suisse Group downgraded LHC Group from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $181.00 to $170.00 in a research note on Wednesday, March 30th. Finally, Benchmark downgraded LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 30th.

Shares of LHC Group stock opened at $157.30 on Friday. LHC Group has a 1 year low of $108.42 and a 1 year high of $216.65. The firm has a market cap of $4.88 billion, a PE ratio of 48.85, a P/E/G ratio of 2.38 and a beta of 0.45. The stock has a fifty day moving average price of $165.00 and a 200-day moving average price of $146.82. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.41 and a quick ratio of 1.41.

LHC Group (NASDAQ:LHCGGet Rating) last announced its quarterly earnings data on Wednesday, May 4th. The health services provider reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.04. LHC Group had a return on equity of 10.11% and a net margin of 4.44%. The company had revenue of $571.50 million during the quarter, compared to analyst estimates of $573.10 million. During the same quarter last year, the firm posted $1.39 EPS. The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. As a group, equities analysts anticipate that LHC Group will post 5.77 EPS for the current fiscal year.

Several large investors have recently made changes to their positions in the company. American Trust bought a new position in shares of LHC Group during the first quarter valued at $216,000. Vise Technologies Inc. purchased a new stake in LHC Group during the first quarter valued at $329,000. Bank of America Corp DE increased its position in LHC Group by 27.9% during the first quarter. Bank of America Corp DE now owns 390,999 shares of the health services provider’s stock valued at $65,923,000 after acquiring an additional 85,244 shares during the last quarter. Walleye Capital LLC purchased a new stake in LHC Group during the first quarter valued at $910,000. Finally, First National Bank of Omaha increased its position in LHC Group by 27.7% during the first quarter. First National Bank of Omaha now owns 58,261 shares of the health services provider’s stock valued at $9,823,000 after acquiring an additional 12,653 shares during the last quarter. 89.65% of the stock is currently owned by hedge funds and other institutional investors.

About LHC Group (Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).

See Also

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.